The results showed that ROS was accumulated as HF occurs in rats (Figure 2(a)); however, κ-OR agonist U50488H can inhibit the release of ROS, reduce MDA contents in plasma, and promote the release of SOD and CAT (Figure 2(b)). Here, SOD1 is linked to hydrops fetalis.